Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$1.35B |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.12B |
| 3 |
Merck
MRK
|
+$763M |
| 4 |
Starbucks
SBUX
|
+$688M |
| 5 |
TSMC
TSM
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$1.64B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$719M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$713M |
| 4 |
COL
Rockwell Collins
COL
|
+$610M |
| 5 |
ANDV
Andeavor
ANDV
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.56% |
| 2 | Financials | 9.82% |
| 3 | Healthcare | 9.37% |
| 4 | Consumer Discretionary | 7.85% |
| 5 | Energy | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Philip Morris
PM
$305B
| $493M | 0.16% |
7,379,052
-1,947,903
| -21% | -$163M |
|
102
Boston Scientific
BSX
$67.6B
| $490M | 0.16% |
13,877,955
-1,854,595
| -12% | -$67.3M |
|
103
NVIDIA
NVDA
$4.76T
| $489M | 0.16% |
146,472,520
+9,374,320
| +7% | +$44.8M |
|
104
State Street SPDR S&P Biotech ETF
XBI
$10.2B
| $481M | 0.15% |
6,703,130
-2,235,877
| -25% | -$180M |
|
105
Humana
HUM
$45.8B
| $475M | 0.15% |
1,656,602
+288,999
| +21% | +$91.6M |
|
106
Altria Group
MO
$122B
| $468M | 0.15% |
9,469,981
-1,263,286
| -12% | -$73.2M |
|
|
TFCF
107
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $467M | 0.15% |
9,783,788
+2,662,213
| +37% | +$125M |
|
108
Costco
COST
$422B
| $461M | 0.15% |
2,262,130
-397,268
| -15% | -$88.7M |
|
109
3M
MMM
$91.9B
| $460M | 0.15% |
2,885,063
-304,832
| -10% | -$50.6M |
|
110
Thermo Fisher Scientific
TMO
$208B
| $459M | 0.15% |
2,051,723
+233,041
| +13% | +$54.7M |
|
111
Broadcom
AVGO
$1.82T
| $459M | 0.15% |
18,049,470
-2,968,530
| -14% | -$70.1M |
|
112
Marathon Petroleum
MPC
$91.2B
| $457M | 0.15% |
7,751,675
+339,929
| +5% | +$23.2M |
|
113
Duke Energy
DUK
$100B
| $456M | 0.15% |
5,288,921
+483,219
| +10% | +$41.1M |
|
114
Tesla
TSLA
$1.22T
| $455M | 0.15% |
20,504,250
+4,146,630
| +25% | +$89.2M |
|
115
NextEra Energy
NEE
$185B
| $453M | 0.14% |
10,430,320
-1,746,076
| -14% | -$76.4M |
|
116
Accenture
ACN
$94.3B
| $442M | 0.14% |
3,136,933
-379,997
| -11% | -$60.1M |
|
117
BP
BP
$109B
| $441M | 0.14% |
12,012,119
+593,082
| +5% | +$23.7M |
|
118
Booking.com
BKNG
$145B
| $440M | 0.14% |
6,389,775
-875,100
| -12% | -$64.2M |
|
119
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.3B
| $436M | 0.14% |
8,583,558
+113,006
| +1% | +$6.13M |
|
120
Cigna
CI
$77B
| $434M | 0.14% |
2,286,420
+25,187
| +1% | +$5.25M |
|
121
Exelon
EXC
$48.2B
| $428M | 0.14% |
13,298,016
-3,753,673
| -22% | -$120M |
|
122
State Street SPDR S&P Regional Banking ETF
KRE
$4.47B
| $425M | 0.14% |
9,073,675
+1,930,566
| +27% | +$103M |
|
123
Vertex Pharmaceuticals
VRTX
$122B
| $422M | 0.13% |
2,545,940
-59,559
| -2% | -$10.3M |
|
124
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.82B
| $421M | 0.13% |
14,923,988
-2,189,118
| -13% | -$64.9M |
|
125
Danaher
DHR
$138B
| $420M | 0.13% |
4,596,647
-196,042
| -4% | -$17.8M |
|
Similar funds
Goldman Sachs's Q4 2018 Portfolio in Review
As of Q4 2018, Goldman Sachs held 6,043 positions worth $314B, down 19% from $387B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs withdrew a net $17.9B in Q4 2018, closing 848 positions and reducing 2,254 holdings. Its most notable exit was Energy Transfer Partners, L.P., an estimated $1.64B position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Goldman Sachs opened a new position in Linde worth $335M.
- Goldman Sachs's largest Q4 2018 buy was Linde: 2,149,240 shares worth $335M.
- Goldman Sachs added most to Energy Transfer Partners in Q4 2018, an estimated $1.35B increase.
- Goldman Sachs's biggest Q4 2018 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $719M.
- Goldman Sachs fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.64B.
- Goldman Sachs's ten largest holdings make up 14% of its $314B portfolio in Q4 2018.
- Goldman Sachs opened 484 new positions and closed 848 in Q4 2018.
- Goldman Sachs's portfolio value fell 19% quarter-over-quarter to $314B.
Based on Goldman Sachs's 13F filing for Q4 2018, filed 14 Feb 2019.